Prostate Cancer - Results from #28160

UroToday Slide Library - Hormone-refractory prostate cancer June 1, 2011

UroToday Slide Library - Prevention of prostate cancer: Is this the way to go? June 1, 2011

UroToday Slide Library - Ongoing trials and the future in hormone refractory prostate cancer June 1, 2011

UroToday Slide Library - Ablatherm® safety on long-term results June 1, 2011

UroToday Slide Library - Patupilone ovarian programme June 1, 2011

UroToday Slide Library - The increasing responsibility of the urologist in maintaining bone health in prostate cancer patients June 1, 2011

UroToday Slide Library - Ablatherm® long-term results as a salvage option after radiotherapy failure June 1, 2011

UroToday Slide Library - Patupilone future development programme June 1, 2011

UroToday Slide Library - Identifying the high risk patient: What is available? June 1, 2011

UroToday Slide Library - The Role Of Bisphosphonates In Metastatic Prostate Cancer June 1, 2011

UroToday Slide Library - Ablatherm® efficiency on long-term results June 1, 2011

UroToday Slide Library - mTOR: A new pathway to target in oncology June 1, 2011

UroToday Slide Library - PSA Nadir: A surrogate marker of long-term efficacy in HIFU therapy for localised prostate cancer June 1, 2011

UroToday Slide Library - The role of surgery in the high risk patient June 1, 2011

UroToday Slide Library - New strategies in the management of advanced neuroendocrine tumors June 1, 2011

UroToday Slide Library - The role of radiation therapy in the high risk patient June 1, 2011

UroToday Slide Library - Chemotherapy for high-risk disease at RRP June 1, 2011

UroToday Slide Library - Conclusions: Patupilone as a novel, alternative microtubule stabilizer June 1, 2011

UroToday Slide Library - The role of bisphosphonates in the high risk patient June 1, 2011

UroToday Slide Library - Treating PSA Recurrence June 1, 2011

Page 1409 of 1453